title: Omalizumab Treatment of Vernal Keratoconjunctivitis.
authors.affiliation: Unit of Respiratory Medicine and Allergology, Department of Clinical and Experimental Medicine, Azienda Ospedaliero Universitaria Policlinico-Vittorio Emanuele Hospital, University of Catania, Catania, Italy.
authors.forename: Enrico
authors.initials: E
authors.lastname: Heffler
authors.affiliation: Unit of Respiratory Medicine and Allergology, Department of Clinical and Experimental Medicine, Azienda Ospedaliero Universitaria Policlinico-Vittorio Emanuele Hospital, University of Catania, Catania, Italy.
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Picardi
authors.affiliation: Unit of Respiratory Medicine and Allergology, Department of Clinical and Experimental Medicine, Azienda Ospedaliero Universitaria Policlinico-Vittorio Emanuele Hospital, University of Catania, Catania, Italy.
authors.forename: Maria Teresa
authors.initials: MT
authors.lastname: Liuzzo
authors.affiliation: Unit of Respiratory Medicine and Allergology, Department of Clinical and Experimental Medicine, Azienda Ospedaliero Universitaria Policlinico-Vittorio Emanuele Hospital, University of Catania, Catania, Italy.
authors.forename: Maria Provvidenza
authors.initials: MP
authors.lastname: Pistorio
authors.affiliation: Unit of Respiratory Medicine and Allergology, Department of Clinical and Experimental Medicine, Azienda Ospedaliero Universitaria Policlinico-Vittorio Emanuele Hospital, University of Catania, Catania, Italy.
authors.forename: Nunzio
authors.initials: N
authors.lastname: Crimi
mesh_terms: D000328:Adult; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D002648:Child; D003233:Conjunctivitis, Allergic / Q000175:diagnosis* / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007150:Immunohistochemistry; D007279:Injections, Subcutaneous; D008297:Male; D000069444:Omalizumab / Q000008:administration & dosage*; D012494:Sampling Studies; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000069444:Omalizumab